Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Tillement

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Bulletin De L'Academie Nationale De Medecine|August 1, 2008
[Self-medication and safety]Jean-Paul Tillement, Pierre Delaveau
CNS & Neurological Disorders Drug Targets|October 31, 2013
Subcellular injuries in Alzheimer's diseaseJean-Paul Tillement, Vassilios Papadopoulos
Current Pharmaceutical Design|March 12, 2009
Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed sideRaphael Thuillier, Jean Paul Tillement, Thierry Hauet
Pharmacology|November 20, 2009
Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological optionsJean-Paul Tillement, Laurent Lecanu, Vassilios Papadopoulos
Biochemical and Biophysical Research Communications|August 2, 2003
Anoxia-reoxygenation-induced cytochrome c and cardiolipin release from rat brain mitochondriaChristophe Morin, Roland Zini, Jean-Paul Tillement
Biochemical Pharmacology|September 25, 2003
Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonistsJean-Paul Tillement, Bernard Testa, Françoise Brée
Bulletin De L'Academie Nationale De Medecine|March 2, 2012
[Ischemia reperfusion: an unavoidable phase of transplant procedures]Thierry Hauet, Raphaël Thuillier, Jean Paul Tillement
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Drug binding to blood proteins: characteristics, roles and pathophysiological changes]Jean-Paul Tillement, Jean-Claude Duché, Jérôme Barré
European Journal of Pharmacology|December 6, 2005
Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liverCatherine Plin, Jean-Paul Tillement, Alain Berdeaux, et al.
European Journal of Pharmacology|May 14, 2003
S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant propertiesAziz Elimadi, Vincent Jullien, Jean Paul Tillement, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Bulletin De L'Academie Nationale De Medecine|August 1, 2008
[Self-medication and safety]Jean-Paul Tillement, Pierre Delaveau
CNS & Neurological Disorders Drug Targets|October 31, 2013
Subcellular injuries in Alzheimer's diseaseJean-Paul Tillement, Vassilios Papadopoulos
Current Pharmaceutical Design|March 12, 2009
Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed sideRaphael Thuillier, Jean Paul Tillement, Thierry Hauet
Pharmacology|November 20, 2009
Amyloidosis and neurodegenerative diseases: current treatments and new pharmacological optionsJean-Paul Tillement, Laurent Lecanu, Vassilios Papadopoulos
Biochemical and Biophysical Research Communications|August 2, 2003
Anoxia-reoxygenation-induced cytochrome c and cardiolipin release from rat brain mitochondriaChristophe Morin, Roland Zini, Jean-Paul Tillement
Biochemical Pharmacology|September 25, 2003
Compared pharmacological characteristics in humans of racemic cetirizine and levocetirizine, two histamine H1-receptor antagonistsJean-Paul Tillement, Bernard Testa, Françoise Brée
Bulletin De L'Academie Nationale De Medecine|March 2, 2012
[Ischemia reperfusion: an unavoidable phase of transplant procedures]Thierry Hauet, Raphaël Thuillier, Jean Paul Tillement
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Drug binding to blood proteins: characteristics, roles and pathophysiological changes]Jean-Paul Tillement, Jean-Claude Duché, Jérôme Barré
European Journal of Pharmacology|December 6, 2005
Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liverCatherine Plin, Jean-Paul Tillement, Alain Berdeaux, et al.
European Journal of Pharmacology|May 14, 2003
S-15176 inhibits mitochondrial permeability transition via a mechanism independent of its antioxidant propertiesAziz Elimadi, Vincent Jullien, Jean Paul Tillement, et al.
Pageof 4